Takeda Pharmaceutical Company Limited announced that its Board of Directors decided to promote Christophe Weber, Representative Director, President & Chief Operating Officer (COO), to Representative Director, President & Chief Executive Officer (CEO), effective April 1, 2015. Yasuchika Hasegawa, Representative Director, Chairman of the Board & CEO, will assume the position of Representative Director, Chairman of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,153 JPY | +1.57% | +0.75% | +2.44% |
09:41am | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
Apr. 26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.44% | 40.94B | |
+26.47% | 664B | |
+27.78% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.64% | 234B | |
+4.95% | 199B | |
-10.14% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical Company Limited Announces Executive Changes